Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ricefidase - Shanghai Bao Pharmaceuticals

Next Previous
Drug Profile

Ricefidase - Shanghai Bao Pharmaceuticals

Alternative Names: KJ-103 - Shanghai Bao Pharmaceuticals

Latest Information Update: 28 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Bao Pharmaceuticals
  • Class Endopeptidases; Recombinant proteins
  • Mechanism of Action Immunoglobulin G degraders
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II/III Immunosuppression
  • Phase II Anti-glomerular basement membrane disease
  • Phase I Autoimmune disorders

Most Recent Events

  • 28 Jun 2025 No recent reports of development identified for phase-I development in Autoimmune-disorders in New Zealand (IV)
  • 18 Jan 2025 Adverse event, pharmacokinetics, pharmacodynamics and immunogenicity data from two phase I trials in Autoimmune disorders released by Shanghai Bao Pharmaceuticals (ChiCTR2300075920) (NCT05274659)
  • 21 Oct 2024 Phase-II clinical trials in Anti-glomerular basement membrane disease in China (IV) (NCT06607016) (CTR20243543)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top